Recurrent Stent Thrombosis in a Patient with Antiphospholipid Syndrome and Dual Anti-Platelet Therapy Non-Responsiveness
Korean Circulation Journal
;
: 71-76, 2015.
Article
in English
| WPRIM
| ID: wpr-166397
ABSTRACT
Antiphospholipid syndrome (APS), the most common acquired hypercoagulable condition, is diagnosed by persistent presence of antiphospholipid antibodies and episodes of vascular thrombosis. It may be an important predisposing factor for stent thrombosis, resulting in poor outcomes. Also, anti-platelet therapy non-responsiveness is associated with stent thrombosis. We report a case of a 39-year-old man who after undergoing successful percutaneous coronary intervention for significant coronary artery disease suffered repeated stent thrombosis events leading to ST-segment elevation myocardial infarction. Eventually, he underwent coronary artery bypass surgery because of uncontrolled thrombosis and was diagnosed as having APS and dual antiplatelet therapy non-responsiveness.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Thrombosis
/
Coronary Artery Disease
/
Stents
/
Coronary Artery Bypass
/
Causality
/
Antiphospholipid Syndrome
/
Antibodies, Antiphospholipid
/
Percutaneous Coronary Intervention
/
Myocardial Infarction
Limits:
Adult
/
Humans
Language:
English
Journal:
Korean Circulation Journal
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS